Skip to content
The Min Lu Research Group
Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)
English
English
中文 (中国)
English
English
中文 (中国)
The Min Lu Research Group
Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)
English
English
中文 (中国)
Home
Research
Achievements
Group News
Scholarly Developments
Life Moments
Research Group Members
Database(rescue p53)
癌症与p53科普-en
Contact Us
Home
Research
Achievements
Group News
Scholarly Developments
Life Moments
Research Group Members
Database(rescue p53)
癌症与p53科普-en
Contact Us
Even if arsenic agents have therapeutic effects, they are only effective against structural p53 mutants
mougen
May 30, 2022
5:14 pm
PANDA Cancer Research Program: Through basic scientific research,
identify mutations in p53 that can be targeted by arsenic agents from over 1000 p53 mutants, forming one of the criteria for arsenic treatment of p53 mutation patients
Prev
上一个
Population with p53 congenital mutations (LFS)
下一个
Although at least 45 teams worldwide are researching drugs to treat p53 mutations, currently only arsenic agents can target p53 mutants and restore their anti-cancer function
Next